The plight of older Australians with motor neurone disease (MND) is a stark reminder of the challenges faced by those with severe disabilities in the aged care system. The case of Glenn Rowan, a 78-year-old man battling MND, highlights the stark financial reality many face when managing this progressive and debilitating disease. With a diagnosis at the age of 71, Rowan is ineligible for the National Disability Insurance Scheme (NDIS) but is forced to rely on the aged care system, which falls far short of the funding needed to provide adequate support.
Rowan's situation is not unique. The aged care system, designed for aging-related needs, struggles to meet the demands of severe disabilities like MND. The Support at Home package, the highest level of which offers up to $78,200, is a mere fraction of the funding available to those on the NDIS. This disparity is further exacerbated by the lack of price caps regulating the cost of at-home care services, leading to a situation where individuals with MND receive inadequate support.
The recent death of AFL star Neale Daniher, who fought MND until the age of 65, brought national attention to this issue. Daniher's case underscores the emotional and financial toll of living with MND, a disease that causes paralysis by damaging nerve cells in the brain and spinal cord. The average life expectancy after MND diagnosis is about 24 months, and the disease's rapid physical deterioration makes it particularly challenging to manage.
The Australian government has responded with a fast-tracked pathway for MND patients, promising funding within 30 days. However, this move falls short of addressing the fundamental issue of inadequate funding. MND Australia's chief executive, Clare Sullivan, warns of the financial strain on families, emphasizing the need for more comprehensive support.
Independent Senator David Pocock echoes these concerns, arguing that individuals with MND have higher needs that should not be financially burdensome. He criticizes the government's automated assessment tool for failing to consider the unique challenges of MND patients, who often require more significant support.
Neurology Professor Dominic Rowe highlights the age-related disparities in MND diagnosis and support. He notes that half of his patients qualify for the NDIS, while the other half, diagnosed just after age 65, receive significantly less funding. This situation often leads to difficult decisions, with some individuals opting for voluntary assisted dying due to the lack of practical care options.
The government's response, however, maintains that the NDIS and Support at Home program are distinct and separate, each serving different purposes. While the NDIS supports those under 65, the Support at Home program caters to aging-related needs, including those with disabilities. Yet, the reality for individuals like Rowan remains a struggle for dignity and financial stability in their final days.
In conclusion, the case of Glenn Rowan and others with MND highlights the urgent need for a reevaluation of the aged care system's approach to severe disabilities. The financial burden and emotional toll of living with MND demand a more compassionate and comprehensive support system. As the government considers its response, it must prioritize the unique needs of MND patients to prevent further financial ruin and ensure a more dignified end-of-life experience.
